Clinical trials
Terminated Amyloidosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tufts Medical Center | 2 |
| Akcea Therapeutics | 1 |
| Alnylam Pharmaceuticals | 1 |
| Brigham and Women's Hospital | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| GlaxoSmithKline | 1 |
| John Mark Sloan | 1 |
| M.D. Anderson Cancer Center | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Oregon Health and Science University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 14 |
| Alzheimer Disease | 1 |
| Amyloid Neuropathies, Familial | 1 |
| Cardiomyopathies | 1 |
| Endocrine System Diseases | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Multiple Myeloma | 1 |
| Neoplasms, Plasma Cell | 1 |
| Paraproteinemias | 1 |
| Polyneuropathies | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.